Q2 2023 Holdings
Filed 2023-08-14 | 41 holdings | $1.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biolife Solutions Inc(BLFS) | COM NEW | 09062W204 | $170.6M | 7,721,535 | 14.9% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $116.2M | 1,015,000 | 10.2% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $75.3M | 5,998,574 | 6.6% |
| Eqrx Inc | COM | 26886C107 | $73.5M | 39,527,669 | 6.4% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $53.2M | 280,000 | 4.6% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $52.0M | 1,275,000 | 4.5% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $48.4M | 1,810,000 | 4.2% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $47.0M | 500,000 | 4.1% |
| Verve Therapeutics Inc | COM | 92539P101 | $44.3M | 2,360,571 | 3.9% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $41.4M | 997,017 | 3.6% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $39.2M | 620,000 | 3.4% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $38.4M | 1,300,000 | 3.4% |
| Tenaya Therapeutics Inc(TNYA) | COM | 87990A106 | $37.5M | 6,381,377 | 3.3% |
| Catalent Inc(CTLTEUR) | COM | 148806102 | $31.2M | 720,000 | 2.7% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $30.8M | 1,700,000 | 2.7% |
| Somalogic Inc(SLGCUSD) | CLASS A COM | 83444K105 | $29.1M | 12,604,275 | 2.5% |
| Illumina Inc(ILMN) | COM | 452327109 | $29.1M | 155,000 | 2.5% |
| Maxcyte Inc(MXCT) | COM | 57777K106 | $21.6M | 4,715,000 | 1.9% |
| 2Seventy BIO Inc(TSVT*) | COMMON STOCK | 901384107 | $20.5M | 2,023,913 | 1.8% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $19.3M | 1,070,000 | 1.7% |
| Genedx Holdings Corp(WGS) | COM CL A | 81663L200 | $18.4M | 3,095,511 | 1.6% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $18.2M | 570,000 | 1.6% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $16.3M | 2,520,000 | 1.4% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $10.1M | 3,206,380 | 0.9% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $9.8M | 2,050,000 | 0.9% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $9.4M | 850,000 | 0.8% |
| Twist Bioscience Corp(TWST) | COM | 90184D100 | $9.2M | 450,000 | 0.8% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $5.4M | 367,175 | 0.5% |
| Incyte Corp(INCY) | COM | 45337C102 | $4.8M | 77,500 | 0.4% |
| Sana Biotechnology Inc(SANA) | COM | 799566104 | $4.5M | 750,000 | 0.4% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $4.2M | 90,000 | 0.4% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $3.5M | 510,882 | 0.3% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $3.3M | 1,000,000 | 0.3% |
| Standard Biotools Inc(LAB) | COM | 34385P108 | $2.3M | 1,200,000 | 0.2% |
| Absci Corporation(ABSI) | COM | 00091E109 | $2.1M | 1,368,260 | 0.2% |
| Exscientia PLC | ADS | 30223G102 | $1.3M | 213,900 | 0.1% |
| Singular Genomics Systems in | COM | 82933R100 | $1.1M | 1,345,722 | 0.1% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $860.4K | 23,814 | 0.1% |
| Lianbio | SPONSORED ADS | 53000N108 | $470.6K | 206,415 | 0.0% |
| Kronos BIO Inc(KRON1USD) | COM | 50107A104 | $213.0K | 123,839 | 0.0% |
| Scilex Holding Co(SCLXUSD) | COM | 80880W106 | $131.0K | 23,512 | 0.0% |